Loss-of-function mutations in SGCE, which encodes ε-sarcoglycan (ε-SG), cause myoclonus-dystonia syndrome (OMIM159900, DYT11). A "major" ε-SG protein derived from CCDS5637.1 (NM_003919.2) and a "brain-specific" protein, that includes sequence derived from alternative exon 11b (CCDS47642.1, NM_001099400.1), are reportedly localized in post-and pre-synaptic membrane fractions, respectively. Moreover, deficiency of the "brainspecific" isoform and other isoforms derived from exon 11b may be central to the pathogenesis of DYT11. However, no animal model supports this hypothesis. Gene-trapped ES cells (CMHD-GT_148G1-3, intron 9 of NM_011360) were used to generate a novel Sgce mouse model (C57BL/6J background) with markedly reduced expression of isoforms derived from exons 3′ to exon 9 of NM_011360. Among those brain regions analyzed in adult (2 month-old) wild-type (WT) mice, cerebellum showed the highest relative expression of isoforms incorporating exon 11b. Homozygotes (Sgce Gt(148G1)Cmhd/Gt(148G1)Cmhd or Sgce Gt/Gt ) and paternal heterozygotes (Sgce m+/pGt , m-maternal, p-paternal) showed 60 to 70% reductions in expression of total Sgce. Although expression of the major (NM_011360) and brain-specific (NM_001130189) isoforms was markedly reduced, expression of short isoforms was preserved and relatively small amounts of chimeric ε-SG/β-galactosidase fusion protein was produced by the Sgce gene-trap locus. Immunoaffinity purification followed by mass spectrometry assessments of Sgce m+/pGt mouse brain using pan-or brain-specific ε-SG antibodies revealed significant reductions of ε-SG and other interacting sarcoglycans. Genome-wide gene-expression data using RNA derived from adult Sgce m+/pGt mouse cerebellum showed that the top up-regulated genes were involved in cell cycle, cellular development, cell death and survival, while the top down-regulated genes were associated with protein synthesis, cellular development, and cell death and survival. In comparison to WT littermates, Sgce m+/pGt mice exhibited "tiptoe" gait and stimulus-induced appendicular posturing between Postnatal Days 14 to 16. Abnormalities noted in older Sgce m+/pGt mice included reduced body weight, altered gait dynamics, and reduced open-field activity.
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Introduction
Myoclonus-dystonia syndrome is a clinically and genetically heterogeneous disorder characterized by myoclonic jerks affecting mainly proximal muscles of the upper extremities, neck and trunk. Mutations (missense, nonsense, splicing, insertions, and deletions) in SGCE represent a major cause of the myoclonus-dystonia syndrome (MDS, DYT11, OMIM159900) (Zimprich et al., 2001; Asmus et al., 2005; Aichhorn et al., 2006) and are believed to cause disease via loss-offunction mechanisms (Kinugawa et al., 2009 , Xiao et al., 2013 . The onset of the disorder is usually in the first or second decade of life. Females tend to have earlier onset and greater probability of leg involvement than males (Raymond et al., 2008) . SGCE is a maternally imprinted gene and MDS is inherited in an autosomal dominant fashion with reduced penetrance (Zimprich et al., 2001) . SGCE encodes the epsilon member of the sarcoglycan (SG) family (ε-SG), single pass transmembrane proteins that are components of the dystrophin- 
